MGTX Research and Charts

MGTX - MeiraGTx Holdings PLC (Healthcare: Biotechnology)

Projected Earnings Date: 2024-08-12 (Delayed quote data 2026-02-10)

Last 7.52	Change ⇓ -0.11 (-1.44%)	Volume 251,232
	Open 7.61	High 7.63	Low 7.50

8EMA (Daily) 7.61	40EMA (Daily) 7.80	50EMA (Daily) 7.84	STO (Daily) 32.154	MACD Hist (Daily) -0.034
8EMA (Weekly) 7.701	40EMA (Weekly) 7.59	50EMA (Weekly) 7.44	STO (Weekly) 24.640	MACD Hist (Weekly) -0.111


Company Profile
MeiraGTx Holdings PLC is a clinical-stage gene therapy company. It focuses on the eye, salivary gland, and central nervous system disorders. The company's pipeline products include AAV-CNGB3, AAV-CNGA3 and AAV-RPGR, and others. Geographically, it operates in the United States, United Kingdom, Ireland, and the Netherlands.

Disclaimer: All information provided is for informational purposes only and not intended for trading purposes or advice. The quotes and charts are not real time and have delays of at least 20 minutes. Data accuracy cannot be guaranteed as errors will occur. Please do not rely on the above information to make your stock/option trades. Neither OptionChance.com nor any of independent data providers is liable for any informational errors, incompleteness, or delays, or for any actions taken in reliance on information contained herein.